Free shipping on all orders over $ 500

Zilovertamab

Cat. No. M25373
Zilovertamab Structure
Synonym:

UC-961; Cirmtuzumab

Size Price Availability Quantity
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Zilovertamab (UC-961) is a humanised monoclonal antibody against ROR1 that blocks Wnt5a-induced ROR1 signalling.

Chemical Information
Storage Please store the product under the recommended conditions in the Certificate of Analysis.
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Kamrul Hasan, et al. Oncotarget. Impact of cortactin in cancer progression on Wnt5a/ROR1 signaling pathway

[2] Boon Kiat Lee, et al. Cancers (Basel). Developing ROR1 Targeting CAR-T Cells against Solid Tumors in Preclinical Studies

[3] Anita Kumar, et al. Am Soc Clin Oncol Educ Book. New Directions for Mantle Cell Lymphoma in 2022

[4] Dongli Liu, et al. Pharmaceutics. The Anti-ROR1 Monoclonal Antibody Zilovertamab Inhibits the Proliferation of Ovarian and Endometrial Cancer Cells

[5] Emanuela M Ghia, et al. Leukemia. High expression level of ROR1 and ROR1-signaling associates with venetoclax resistance in chronic lymphocytic leukemia

Related ROR Products
JTE-151

JTE-151 is a RORγ inhibitor that suppresses overactive immune responses by inhibiting RORγ associated with Th17 cell activation.JTE-151 can be used in studies related to autoimmune diseases.

SAR-441169

SAR-441169 is a RORγt inverse agonist that can be used in studies related to psoriasis.

GRC-39815

GRC-39815 is a RORγt inverse agonist that can be used in studies related to chronic obstructive pulmonary disease.

RORγ antagonist 1

RORγ antagonist 1, a potent betulinic acid derivative, is an antagonist of RORγ (KD=0.18 μM).

RORγt inverse agonist 31

RORγt inverse agonist 31 (14g) is a potent retinoic acid receptor-related orphan receptor γt (RORγt) inverse agonist, with an IC50 of 0.428 μM.

  Catalog
Abmole Inhibitor Catalog




Keywords: Zilovertamab, UC-961; Cirmtuzumab supplier, ROR, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.